{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:08:15Z","timestamp":1788822495374,"version":"build-2803163510"},"reference-count":26,"publisher":"Georg Thieme Verlag KG","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1055\/a-2711-2298","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:36:47Z","timestamp":1788820607000},"page":"995-1002","source":"Crossref","is-referenced-by-count":0,"title":["Adenokarzinome des gastro\u00f6sophagealen \u00dcbergangs und Magens: Aktuelles Management"],"prefix":"10.1055","volume":"151","author":[{"given":"Yvonne","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"ref3","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"P Correa","year":"1992","journal-title":"Cancer Res"},{"issue":"12","key":"ref4","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis","volume":"69","author":"AC Ford","year":"2020","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000550791","article-title":"What Is New in the German S3 Guideline on Gastric Cancer: Diagnosis, Staging, and Treatment","volume":"49","author":"M Moehler","year":"2026","journal-title":"Oncol Res Treat"},{"issue":"12","key":"ref6","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3390\/jpm12122032","article-title":"Hereditary Diffuse Gastric Cancer: A 2022 Update","volume":"12","author":"C Kole","year":"2022","journal-title":"J Pers Med"},{"issue":"02","key":"ref7","doi-asserted-by":"publisher","first-page":"e12563","DOI":"10.1111\/hel.12563","article-title":"Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases","volume":"24","author":"Q Chen","year":"2019","journal-title":"Helicobacter"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"101735","DOI":"10.1016\/j.bpg.2021.101735","article-title":"Cost-effectiveness of prevention and early detection of gastric cancer in Western countries","volume":"50\/51","author":"I Lansdorp-Vogelaar","year":"2021","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/gutjnl-2023-331164","article-title":"RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates","volume":"73","author":"M Rugge","year":"2024","journal-title":"Gut"},{"issue":"S 16","key":"ref10","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC\/GEJC) following neoadjuvant chemoradiotherapy (CRT): First results of overall survival (OS) from CheckMate 577","volume":"43","author":"RJ Kelly","year":"2025","journal-title":"J Clin Oncol"},{"issue":"07","key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071310","article-title":"Autoimmune Atrophic Gastritis: A Clinical Review","volume":"16","author":"C Castellana","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"11","key":"ref12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1055\/a-1611-5091","article-title":"Endoscopic tissue sampling \u2013 Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"53","author":"RE Pouw","year":"2021","journal-title":"Endoscopy"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/his.13816","article-title":"Upper GI biopsies for adenocarcinoma \u2013 how many biopsies should endoscopists take?","volume":"74","author":"P Kaye","year":"2019","journal-title":"Histopathology"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12957-017-1176-6","article-title":"Endoscopic ultrasonography compared with multidetector computed tomography for the preoperative staging of gastric cancer: a meta-analysis","volume":"15","author":"RC Nie","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"01","key":"ref15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7800-2-3","article-title":"Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer","volume":"2","author":"RL Harmon","year":"2005","journal-title":"Int Semin Surg Oncol"},{"issue":"03","key":"ref16","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3390\/curroncol29030151","article-title":"Laparoscopic vs. Open Gastrectomy for Locally Advanced Gastric Cancer: A Propensity Score-Matched Retrospective Case-Control Study","volume":"29","author":"S Caruso","year":"2022","journal-title":"Curr Oncol"},{"issue":"03","key":"ref17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/SLA.0b013e31824682f4","article-title":"Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies","volume":"255","author":"EF Vi\u00f1uela","year":"2012","journal-title":"Ann Surg"},{"issue":"29","key":"ref19","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO-25-00486","article-title":"Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study","volume":"43","author":"K Shitara","year":"2025","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1200\/JCO.23.00975","article-title":"Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II\/III DANTE\/IKF-s633 Trial","volume":"42","author":"S Lorenzen","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"S877","DOI":"10.1016\/j.annonc.2024.08.1466","article-title":"1400O Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G\/GEJ adenocarcinoma","volume":"35","author":"YY Janjigian","year":"2024","journal-title":"Ann Oncol"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s10120-014-0402-y","article-title":"HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer","volume":"18","author":"E Van Cutsem","year":"2015","journal-title":"Gastric Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"YY Janjigian","year":"2021","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.annonc.2026.02.003","article-title":"Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649","volume":"37","author":"YY Janjigian","year":"2026","journal-title":"Ann Oncol"},{"key":"ref25","first-page":"6","article-title":"Tumoren des Gastrointestinaltrakts: Chemoimmunotherapien \u2013 Nebenwirkungen im Griff","volume":"4","author":"O Waidmann","year":"2023","journal-title":"Dtsch Arztebl"},{"issue":"12","key":"ref26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma","volume":"391","author":"K Shitara","year":"2024","journal-title":"N Engl J Med"},{"issue":"06","key":"ref27","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1038\/s41591-026-04306-9","article-title":"First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial","volume":"32","author":"K Shitara","year":"2026","journal-title":"Nat Med"},{"issue":"S 2","key":"ref28","first-page":"LBA285","article-title":"Zanidatamab + chemotherapy (CT) \u00b1 tislelizumab for first-line (1L) HER2-positive (HER2+) locally advanced, unresectable, or metastatic gastroesophageal adenocarcinoma (mGEA): Primary analysis from HERIZON-GEA-01","volume":"44","author":"E Elimova","year":"2026","journal-title":"J Clin Oncol"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2711-2298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:36:51Z","timestamp":1788820611000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2711-2298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9,7]]},"published-print":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2711-2298","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}